Miracle-dz/UniFAR-FTUs huggingface dataset:
Promoting consistent use of the communication function classification system (CFCS)

Abstract Purpose: We developed a Knowledge Translation (KT) intervention to standardize the way speech-language pathologists working in Ontario Canada’s Preschool Speech and Language Program (PSLP) used the Communication Function Classification System (CFCS). This tool was being used as part of a provincial program evaluation and standardizing its use was critical for establishing reliability and validity within the provincial dataset. Method: Two theoretical foundations – Diffusion of Innovations and the Communication Persuasion Matrix – were used to develop and disseminate the intervention to standardize use of the CFCS among a cohort speech-language pathologists. A descriptive pre-test/post-test study was used to evaluate the intervention. Fifty-two participants completed an electronic pre-test survey, reviewed intervention materials online, and then immediately completed an electronic post-test survey. Results: The intervention improved clinicians’ understanding of how the CFCS should be used, their intentions to use the tool in the standardized way, and their abilities to make correct classifications using the tool. Conclusions: Findings from this work will be shared with representatives of the Ontario PSLP. The intervention may be disseminated to all speech-language pathologists working in the program. This study can be used as a model for developing and disseminating KT interventions for clinicians in paediatric rehabilitation. Implications for Rehabilitation The Communication Function Classification System (CFCS) is a new tool that allows speech-language pathologists to classify children’s skills into five meaningful levels of function. There is uncertainty and inconsistent practice in the field about the methods for using this tool. This study used combined two theoretical frameworks to develop an intervention to standardize use of the CFCS among a cohort of speech-language pathologists. The intervention effectively increased clinicians’ understanding of the methods for using the CFCS, ability to make correct classifications, and intention to use the tool in the standardized way in the future.
Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells

Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) demonstrates potent anti-cancer activity. We previously demonstrated that 14C-Dp44mT enters and targets cells through a carrier/receptor-mediated uptake process. Despite structural similarity, 2-benzoylpyridine 4-ethyl-3-thiosemicarbazone (Bp4eT) and pyridoxal isonicotinoyl hydrazone (PIH) enter cells via passive diffusion. Considering albumin alters the uptake of many drugs, we examined the effect of human serum albumin (HSA) on the cellular uptake of Dp44mT, Bp4eT and PIH. Chelator-HSA binding studies demonstrated the following order of relative affinity: Bp4eT≈PIH>Dp44mT. Interestingly, HSA decreased Bp4eT and PIH uptake, potentially due to its high affinity for the ligands. In contrast, HSA markedly stimulated Dp44mT uptake by cells, with two saturable uptake mechanisms identified. The first mechanism saturated at 5-10 μM (Bmax:1.20±0.04 × 107 molecules/cell; Kd:33±3 μM) and was consistent with a previously identified Dp44mT receptor/carrier. The second mechanism was of lower affinity, but higher capacity (Bmax:2.90±0.12 × 107 molecules/cell; Kd:65±6 μM), becoming saturated at 100 μM and was only evident in the presence of HSA. This second saturable Dp44mT uptake process was inhibited by excess HSA and had characteristics suggesting it was mediated by a specific binding site. Significantly, the HSA-mediated increase in the targeting of Dp44mT to cancer cells potentiated apoptosis and could be important for enhancing efficacy.
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.

Cytochrome P450 3A (CYP3A) metabolizes a diverse array of clinically important drugs. For some of these (e.g., cyclosporine, verapamil, midazolam), CYP3A in the intestinal mucosa contributes to their extensive and variable first-pass extraction. To further characterize this phenomenon, we measured CYP3A content and catalytic activity toward the probe substrate midazolam in mucosa isolated from duodenal, jejunal and ileal sections of 20 human donor intestines. For comparison, the same measurements were performed for 20 human donor livers, eight of which were obtained from the same donors as eight of the intestines. Excellent correlations existed between homogenate and microsomal CYP3A content for the three intestinal regions. Median microsomal CYP3A content was greatest in the duodenum and lowest in the ileum (31 vs. 17 pmol/mg of protein). With respect to midazolam 1'-hydroxylation kinetics, the median Km for each intestinal region was similar to the median hepatic Km, approximately 4 microM. In contrast, the median Vmax decreased from liver to duodenum to jejunum to ileum (850 vs. 644 vs. 426 vs. 68 pmol/min/mg). Intrinsic clearance (Vmax/Km) followed a similar trend for the intestinal regions; median duodenal intrinsic clearance was comparable to hepatic intrinsic clearance (157 and 200 microl/min/mg, respectively). Vmax correlated with CYP3A content for all tissues except the ileum. Duodenal and jejunal Vmax and CYP3A content varied by >30-fold among donors. Microsomes prepared from every other 1-foot section of six intestines were also analyzed for CYP3A as well as for two coenzymes. In general, CYP3A activity, CYP3A content and CYP reductase activity rose slightly from duodenum to middle jejunum and then declined to distal jejunum and ileum. Cytochrome b5 content and cytochrome b5 reductase activity varied little throughout the intestinal tract. Regional intrinsic midazolam 1'-hydroxylation clearance was greatest for the jejunum, followed by the duodenum and ileum (144, 50 and 19 ml/min, respectively). Collectively, these results demonstrate that the upper small intestine serves as the major site for intestinal CYP3A-mediated first-pass metabolism and provides a rationale for interindividual differences in oral bioavailability for some CYP3A substrates.
An Energy-Efficient Design for ECG Recording and R-Peak Detection Based on Wavelet Transform

Long-term monitoring of electrocardiogram (ECG) requires a portable inspection system that can offer both high energy efficiency and good signal quality. To manage challenges caused by this requirement, this brief presents an ASIC design for both ECG recording and R-peak detection. By supporting data compression and using a dual-ping-pong-memory architecture, this design leads to a large reduction in the whole system energy. To reduce the hardware cost, the techniques of coefficients truncation and resource sharing are adopted. Importantly, parameters optimization and periodic extension are employed to improve quality of the reconstructed signal under high compress ratio (CR). Experimental results based on MIT-BIH database show that the proposed design obtains a high CR of 10.3 with a percentage root-mean-square difference of 0.64% under recording mode, and it achieves an R-peak detection sensitivity of 99.72% as well as a positive prediction of 99.49% with 13.68× data reduction. This design has been fabricated under TSMC 65-nm CMOS technology with area cost of 0.41 mm2. Measurement results indicate that the total system energy consumption for processing one segment of signals can be reduced by 5.7× and 2.3× in recording and detection modes, respectively. Compared to a software implementation on the same chip, this ASIC implementation achieves a 41% and 50% reduction in energy consumption per sample under the two modes, respectively.
Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma

We recently defined event‐free survival at 24 months (EFS24) as a clinically relevant outcome for patients with DLBCL. Patients who fail EFS24 have very poor overall survival, while those who achieve EFS24 have a subsequent overall survival equivalent to that of the age‐ and sex‐matched general population. Here, we develop and validate a clinical risk calculator (IPI24) for EFS24. Model building was performed on a discovery dataset of 1,348 patients with DLBCL and treated with anthracycline‐based immunochemotherapy. A multivariable model containing age, Ann Arbor stage, normalized serum LDH, ALC, ECOG performance status, bulky disease, and sex was identified. The model was then applied to an independent validation dataset of 1,177 DLBCL patients. The IPI24 score estimates the probability of failing to achieve the EFS24 endpoint for an individual patient. The IPI24 model showed superior discriminatory ability (c‐statistic = 0.671) in the validation dataset compared to the IPI (c‐statistic = 0.649) or the NCCN‐IPI (c‐statistic = 0.657). After recalibration of the model on the combined dataset, the median predicted probability of failing to achieve EFS24 was 36% (range, 12–88%), and the IPI24 showed an EFS24 gradient in all IPI groups. The IPI24 also identified a significant percentage of patients with high risk disease, with over 20% of patients having a 50% or higher risk of failing to achieve EFS24. The IPI24 provides an individual patient level probability of achieving the clinically relevant EFS24 endpoint. It can be used via electronic apps. Am. J. Hematol. 91:179–184, 2016. © 2015 Wiley Periodicals, Inc.
Challenges in identifying the methodology to estimate the prevalence of infectious intestinal disease in Malta

Routine surveillance systems capture only a fraction of infectious intestinal disease (IID) that is actually occurring in the community. Different methodologies utilized among various international studies in the field were reviewed in order to devise an appropriate survey to obtain current estimates of prevalence of IID in Malta. An age-stratified retrospective cross-sectional telephone study was selected for the study due to its feasibility in terms of limited resources necessary (funds, time and human). The disadvantages of this type of study include the inherent biases such as selection bias (sampling, ascertainment and participation bias) and information bias (recall and observer bias). A pilot study was carried out using a random age-stratified sample of 100 persons over a 3-month period. A total of 5·0% (95% CI ±4·27) of the population was estimated to have suffered from IID during that period. This estimate was used in order to assist in sample size calculations for a large-scale community study. It also served to test the survey instrument and methodology and to identify operational problems.
Principles and prevention of corrosion

1. The Technology and Evaluation of Corrosion. 2. Electrochemical Thermodynamics and Electrode Potential. 3. Electrochemical Kinetics of Corrosion. 4. Passivity. 5. Polarization Methods to Measure Corrosion Rate. 6. Galvanic and Concentration Cell Corrosion. 7. Pitting and Crevice Corrosion. 8. Environmentally Induced Cracking. 9. Effects of Metallurgical Structure on Corrosion. 10. Corrosion-Related Damage by Hydrogen, Erosion, and Wear. 11. Corrosion in Selected Corrosive Environments. 12. Atmospheric Corrosion and Elevated Temperature Oxidation. 13. Cathodic Protection. 14. Coatings and Inhibitors. 15. Materials Selection and Design. Index.
Protective effect of Glycine max and Chrysanthemum indicum extracts against cisplatin-induced renal epithelial cell death

Although cisplatin is one of the most efficient chemotherapeutic agents for the treatment of solid tumors, frequently observed nephrotoxicity has limited its use in several patients. Materials and methods: The protective effect of Glycine max (GM) and Chrysanthemum indicum (CM) extracts on cisplatin-induced apoptosis in human proximal tubular HK-2 cells was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Hoechst 33342, and propidium iodide assays. Reactive oxygen species (ROS) were determined by flow cytometry with 2,7-dichlorofluorescein diacetate (DCFH2-DA). Results: Cisplatin-induced renal cell toxicity through the induction of hydrogen peroxide (H2O2•−) and hydroxyl radical (OH). CM extract protected cisplatin-induced apoptosis by its anti-oxidant activity against H2O2 and OH•−, while GM extract scavenged only H2O2. Furthermore, GM and CM extracts protect renal cells without significant interfering effect on cisplatin toxicity in lung cancer H460 and melanoma G361 cells. Conclusion: GM and CM extracts exhibited a promising protective effect on cisplatin-induced nephrotoxicity which could benefit the development for nephroprotective approaches.
The ability to self-monitor performance during a week of simulated night shifts.

STUDY OBJECTIVES Research has indicated that individuals are able to accurately monitor the performance decrements they experience during unitary periods of acute sleep deprivation. The aim of the current study was to investigate the ability to self-monitor performance during a week of simulated night shifts. DESIGN Subjects completed 7 consecutive 8-hour night shifts (11 pm-7 am). SETTING University sleep laboratory. SUBJECTS Fifteen young (7 men, 8 women, 19-25 years) healthy volunteers. INTERVENTIONS During the night shifts, performance was measured hourly on 4 performance parameters: psychomotor vigilance test (PVT), tracking, and grammatical reasoning (GRG) accuracy and response latency. Before and after each test, subjects completed visual analogue scales, which required them to rate their alertness and their performance speed and/or accuracy. RESULTS Analysis indicated that GRG response latency and tracking were significantly impaired (P<0.05) during the first 2 shifts only. The PVT performance displayed consistent impairment, with significant (P<0.05) declines during all but the final shift. The pattern of deterioration in subjective ratings of alertness was similar to that of the PVT data. Correlations between subjective alertness and self-ratings of performance were significant (P<0.01) for all parameters (r=0.39-0.69). Significant (P<0.05) correlations were found across the week between pretest performance ratings and actual performance for all parameters except GRG accuracy (r=0.29-0.58) and between posttest ratings and actual performance for all parameters (r=0.52-0.75). Correlations between pretest ratings and actual performance were also conducted separately for each shift. Highest correlations were found during the first shift, with r-values that were low for GRG accuracy (r=0.32) and GRG response latency (r=0.20), moderate for tracking (r=0.41), and high for PVT (r=0.82). In general, lower correlations were found later in the week. CONCLUSIONS Overall, results indicate that individuals have only a moderate ability to predict performance impairment during a week of night shifts. It is likely that performance ratings are based, at least to a certain extent, on subjective alertness levels. Furthermore, it seems that rating accuracy is improved on tasks providing performance feedback, such as the PVT. Finally, it appears that after testing, individuals have a more accurate perception of their performance.
Acculturation and Outcomes Among Patients With Heart Failure

Background—Acculturation to US society among minority patients may—beyond race and ethnicity alone—influence health outcomes beyond race and ethnicity alone. In particular, those who are foreign-born and who do not speak English as their primary language may have greater challenges interacting with the health care system and thus be at greater risk for adverse outcomes. Methods and Results—We studied patients hospitalized with a principal discharge diagnosis of heart failure between January 2000 and December 2007 in an integrated delivery system that cares for minority patients. Individuals were defined as having low acculturation if their primary language was not English and their country of birth was outside of the United States. Multivariable logistic regression and Cox proportional hazards regression were used to determine the independent risk of 30-day rehospitalization and 1-year mortality, respectively. Candidate adjustment variables included demographics (age, sex, race/ethnicity), coexisting illnesses, laboratory values, left ventricular systolic function, and characteristics of the index admission. Of 1268 patients, 30% (n=379) were black, 39% (n=498) were Hispanic, and 27% (n=348) were white. Eighteen percent (n=228) had low acculturation. After adjustment, low acculturation was associated with a higher risk of readmission at 30 days (odds ratio, 1.70; 95% confidence interval, 1.07–2.68) but not 1-year all-cause mortality (hazard ratio, 0.69; 95% confidence interval, 0.42–1.14). Conclusions—Patients with heart failure who are foreign-born and do not speak English as their primary language have a greater risk of rehospitalization, independent of clinical factors and race/ethnicity. Future studies should evaluate whether culturally concordant interventions focusing on such patients may improve outcomes for this patient population.
ERα Signaling Is Required for TrkB-Mediated Hippocampal Neuroprotection in Female Neonatal Mice after Hypoxic Ischemic Encephalopathy

Abstract Male neonate brains are more susceptible to the effects of perinatal asphyxia resulting in hypoxia and ischemia (HI)-related brain injury. The relative resistance of female neonatal brains to adverse consequences of HI suggests that there are sex-specific mechanisms that afford females greater neuroprotection and/or facilitates recovery post-HI. We hypothesized that HI preferentially induces estrogen receptor α (ERα) expression in female neonatal hippocampi and that ERα is coupled to Src family kinase (SFK) activation that in turn augments phosphorylation of the TrkB and thereby results in decreased apoptosis. After inducing the Vannucci’s HI model on P9 (C57BL/6J) mice, female and male ERα wild-type (ERα+/+) or ERα null mutant (ERα−/−) mice received vehicle control or the selective TrkB agonist 7,8-dihydroxyflavone (7,8-DHF). Hippocampi were collected for analysis of mRNA of ERα and BDNF, protein levels of ERα, p-TrkB, p-src, and cleaved caspase 3 (c-caspase-3) post-HI. Our results demonstrate that: (1) HI differentially induces ERα expression in the hippocampus of the female versus male neonate, (2) src and TrkB phosphorylation post-HI is greater in females than in males after 7,8-DHF therapy, (3) src and TrkB phosphorylation post-HI depend on the presence of ERα, and (4) TrkB agonist therapy decreases the c-caspase-3 only in ERα+/+ female mice hippocampus. Together, these observations provide evidence that female-specific induction of ERα expression confers neuroprotection with TrkB agonist therapy via SFK activation and account for improved functional outcomes in female neonates post-HI.
Matérn Cross-Covariance Functions for Multivariate Random Fields

We introduce a flexible parametric family of matrix-valued covariance functions for multivariate spatial random fields, where each constituent component is a Matérn process. The model parameters are interpretable in terms of process variance, smoothness, correlation length, and colocated correlation coefficients, which can be positive or negative. Both the marginal and the cross-covariance functions are of the Matérn type. In a data example on error fields for numerical predictions of surface pressure and temperature over the North American Pacific Northwest, we compare the bivariate Matérn model to the traditional linear model of coregionalization.
Starting antidepressant use: a qualitative synthesis of UK and Australian data

Objective To explore people's experiences of starting antidepressant treatment. Design Qualitative interpretive approach combining thematic analysis with constant comparison. Relevant coding reports from the original studies (generated using NVivo) relating to initial experiences of antidepressants were explored in further detail, focusing on the ways in which participants discussed their experiences of taking or being prescribed an antidepressant for the first time. Participants 108 men and women aged 22–84 who had taken antidepressants for depression. Setting Respondents recruited throughout the UK during 2003–2004 and 2008 and 2012–2013 and in Australia during 2010–2011. Results People expressed a wide range of feelings about initiating antidepressant use. People's attitudes towards starting antidepressant use were shaped by stereotypes and stigmas related to perceived drug dependency and potentially extreme side effects. Anxieties were expressed about starting use, and about how long the antidepressant might begin to take effect, how much it might help or hinder them, and about what to expect in the initial weeks. People worried about the possibility of experiencing adverse effects and implications for their senses of self. Where people felt they had not been given sufficient time during their consultation information or support to take the medicines, the uncertainty could be particularly unsettling and impact on their ongoing views on and use of antidepressants as a viable treatment option. Conclusions Our paper is the first to explore in-depth patient existential concerns about start of antidepressant use using multicountry data. People need additional support when they make decisions about starting antidepressants. Health professionals can use our findings to better understand and explore with patients’ their concerns before their patients start antidepressants. These insights are key to supporting patients, many of whom feel intimidated by the prospect of taking antidepressants, especially during the uncertain first few weeks of treatment.
Nuclear Import of the Yeast Hexokinase 2 Protein Requires α/β-Importin-dependent Pathway*

Background: Yeast hexokinase 2 shuttles in and out of nucleus in response to glucose availability. Results: Hexokinase 2 enters the nucleus by binding Kap60 through a nuclear localization sequence in the presence of Kap95. Conclusion: The karyopherins Kap60 and Kap95 are necessary for efficient nuclear import of hexokinase 2. Significance: The current study has identified a new pathway for Hxk2 import into the nucleus. Hexokinase 2 (Hxk2) from Saccharomyces cerevisiae was one of the first metabolic enzymes described as a multifunctional protein. Hxk2 has a double subcellular localization and role, it functions as a glycolytic enzyme in the cytoplasm and as a regulator of gene transcription of several Mig1-regulated genes in the nucleus. However, the mechanism by which Hxk2 enters in the nucleus was unknown until now. Here, we report that the Hxk2 protein is an import substrate of the carriers α-importin (Kap60 in yeast) and β-importin (Kap95 in yeast). We also show that the Hxk2 nuclear import and the binding of Hxk2 with Kap60 are glucose-dependent and involve one lysine-rich nuclear localization sequence (NLS), located between lysine 6 and lysine 12. Moreover, Kap95 facilitates the recognition of the Hxk2 NLS1 motif by Kap60 and both importins are essential for Hxk2 nuclear import. It is also demonstrated that Hxk2 nuclear import and its binding to Kap95 and Kap60 depend on the Gsp1-GTP/GDP protein levels. Thus, our study uncovers Hxk2 as a new cargo for the α/β-importin pathway of S. cerevisiae.
Combinatorial bounds via measure and conquer: Bounding minimal dominating sets and applications

We provide an algorithm listing all minimal dominating sets of a graph on <i>n</i> vertices in time <i>O</i>(1.7159<sup><i>n</i></sup>). This result can be seen as an algorithmic proof of the fact that the number of minimal dominating sets in a graph on <i>n</i> vertices is at most 1.7159<sup><i>n</i></sup>, thus improving on the trivial <i>O</i>(2<sup><i>n</i></sup>/&sqrt;<i>n</i>) bound. Our result makes use of the measure-and-conquer technique which was recently developed in the area of exact algorithms. Based on this result, we derive an <i>O</i>(2.8718<sup><i>n</i></sup>) algorithm for the domatic number problem.